Richard Bernstein Advisors LLC Sells 32,867 Shares of Corteva, Inc. $CTVA

Richard Bernstein Advisors LLC reduced its position in shares of Corteva, Inc. (NYSE:CTVA) by 62.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 19,413 shares of the company’s stock after selling 32,867 shares during the quarter. Richard Bernstein Advisors LLC’s holdings in Corteva were worth $1,313,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Activest Wealth Management lifted its stake in Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after buying an additional 200 shares in the last quarter. True Wealth Design LLC increased its position in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after acquiring an additional 264 shares during the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva during the 2nd quarter worth approximately $27,000. Twin Peaks Wealth Advisors LLC bought a new stake in Corteva during the second quarter worth $29,000. Finally, Redmont Wealth Advisors LLC bought a new stake in shares of Corteva in the 3rd quarter valued at about $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.15% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CTVA shares. Rothschild & Co Redburn lowered their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a report on Tuesday, November 11th. Jefferies Financial Group upped their price objective on shares of Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. BNP Paribas Exane lifted their price target on shares of Corteva from $72.00 to $74.00 in a report on Monday. Finally, Wells Fargo & Company upped their target price on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average price target of $82.90.

Corteva Stock Performance

Shares of Corteva stock opened at $76.30 on Wednesday. The business has a 50-day simple moving average of $73.40 and a 200 day simple moving average of $69.06. The firm has a market capitalization of $51.31 billion, a price-to-earnings ratio of 48.29, a PEG ratio of 2.68 and a beta of 0.72. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $53.40 and a one year high of $80.90.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the firm earned $0.32 earnings per share. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.